Michael Gutch - 19 Oct 2021 Form 4 Insider Report for Entasis Therapeutics Holdings Inc. (ETTX)

Role: Chief Financial Officer and Chief Business Officer
Signature: Michael Gutch
Issuer symbol: ETTX
Transactions as of: 19 Oct 2021
Transactions value $: -$11,991
Form type: 4
Filing time: 20 Oct 2021, 16:09:32 UTC
Previous filing: 15 Feb 2022
Next filing: 03 Nov 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ETTX	Common Stock	Award	$0	+25,000	+100%	$0	50,000	19 Oct 2021	Direct	F1
transaction	ETTX	Common Stock	Sale	-$11,991	-3,759	-7.5%	$3.19	46,241	19 Oct 2021	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Acquired as a result of the satisfaction of the performance criteria of the underlying award as of the date stated. Fifty percent of this award vested on such date and the remaining fifty percent will vest on the first anniversary of such date, subject to the reporting person's continued employment with the Company.
F2	Represents shares sold solely for purposes of the payment of taxes arising in connection with the vesting of restricted stock units on October 19, 2021. The number of shares sold was determined based on the closing price on the last trading day prior to vesting, which was October 18, 2021.

Remarks:

Chief Financial Officer and Chief Business Officer